Why biotechs are talking about 2023 - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 68%

Business News News

Business Business Latest News,Business Business Headlines

See our list of first-quarter Bay Area biotech clinical milestones — and help us add to it.

Biotech's fast-revving engine of the past decade has pulled in for a tuneup.Last month's J.P. Morgan Healthcare Conference served as a way for investors to push the check-engine light. If the engine starts to sound smooth to investors, maybe they'll jump in for a ride.

On the readout side, Bridge Bio has at least two big events this year: one in late February or early March for a mid-stage study of its oral drug infigratinib to treat achondroplasia, a bone growth disorder that is the most common type of short-limbed dwarfism; the other is Phase III trial data in July for acoramidis, its experimental orally administered treatment for transthyretin amyloidosis, a condition where clumps of protein build up in the heart.

"A substantial number of companies need to tap financial markets this year," Kumar said."That puts the focus on this year and 'how do I get people to keep their eyes on this.'" But around Labor Day last year, Dice needed to make a decision on whether to hire more people for a potential mid-stage clinical trial while not knowing whether the Phase I study data coming in October would be good or bad."Understaffing I can deal with — you just hire more people," Judice said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bay Area Business Owner at the State of the Union AddressThere were plenty of everyday citizens who were invited to the State of the Union Tuesday. Chuck Hammers, the owner of Bay Area-based Pizza My Heart was in the House chamber. Congressman Jimmy Panetta invited him to represent the many businesses that were impacted by the recent storms. “Everyday people” don’t own successful pizza chains. “Everyday people” eat at successful pizza chains
Source: nbcbayarea - 🏆 596. / 51 Read more »